Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms such as bradykinesia, rigidity, and tremor, alongside a ...

With over 10 million people affected worldwide, Parkinson's disease is the fastest-growing neurological disorder. More than ...

Repetitive transcranial magnetic stimulation (rTMS) of the brain is a noninvasive, well-tolerated technique that can modify cerebral cortex ... rTMS for motor function in Parkinson disease ...

Researchers from Mass General Brigham identified therapeutic targets that may optimize symptom-specific treatment for Parkinson ... connected to the primary motor cortex and cerebellum, while ...

US-based pharmaceutical company AbbVie has reported that the Phase III TEMPO-2 trial of tavapadon, its D1/D5 partial agonist candidate for early-stage Parkinson's disease, met its primary endpoint.

Recently, the researchers identified two distinct subpopulations of mitral/tufted (M/T) cells within the OB that project to the anterior piriform cortex (aPC) and entorhinal cortex (EC). These neural ...

New research suggests that dancing might lighten the depression suffered by many people with Parkinson’s disease, an approach ...

The primary endpoint was ... injuries in people living with Parkinson's disease. Pirepemat is designed to strengthen nerve cell signaling in the prefrontal cortex via antagonism at 5HT7 and ...